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http:WHAT THIS PAPER ADDS
This is the ﬁrst longitudinal study to use duplex scanning to report on the epidemiology of venous reﬂux in an
adult population. The results showed that approximately 1% of the adult population develops venous reﬂux each
year, the majority of which is in the superﬁcial leg veins. Furthermore, venous reﬂux increased the risk of
developing varicose veins, particularly when combined deep and superﬁcial reﬂux was present.Objective/background: Chronic venous disease (CVD) is common, but the incidence of venous reﬂux, a precursor
to this condition, is unknown. This study measured the incidence of venous reﬂux and associated risk factors, and
examined the association between venous reﬂux and the incidence of CVD.
Methods: In the Edinburgh Vein Study, a random sample of 1566 men and women aged 18e64 years were
examined at baseline. Eight hundred and eighty of these patients were followed up 13 years and underwent an
examination comprising clinical classiﬁcation of CVD and duplex scanning of the deep and superﬁcial systems to
measure venous reﬂux 0.5 s.
Results: The 13-year incidence of reﬂux was 12.7% (95% conﬁdence interval [CI] 9.2e17.2), equivalent to an annual
incidence of 0.9% (95% CI 0.7e1.3).The 13-year incidence of isolated superﬁcial, isolated deep, and combined deep
and superﬁcial reﬂux was 8.8% (95% CI 5.6e12.0), 2.6% (95% CI 1.2e5.0), and 1.3% (95% CI 0.4e3.2), respectively.
The highest incidencewas in the great saphenous vein in the lower thigh (8.1%, 95%CI 5.4e11.8).Therewere no age
or sexdifferences (p> .050).The risk of developing reﬂuxwas associatedwith being overweight (odds ratio [OR] 2.1,
95% CI 1.0e4.4) and with history of deep vein thrombosis (OR 11.3, 95% CI 1.0e132.3). Venous reﬂux at baseline
was associated with new varicose veins at follow up (p< .001): the age- and sex-adjusted OR was 4.4 (95% CI 1.8e
10.8) in those with isolated superﬁcial reﬂux and 7.3 (95% CI 2.6e22.5) in those with combined deep and superﬁcial
reﬂux.
Conclusion: For every year of follow-up, around 1% of this adult population developed venous reﬂux. In two
thirds of cases, the superﬁcial system was affected. Venous reﬂux increased the risk of developing varicose veins,
especially when combined deep and superﬁcial reﬂux was present.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Varicose veins affect up to 40% of the general population.1e
5 They are often the result of venous hypertension due to
reﬂux of blood through incompetent valves or venous
obstruction, and may be exacerbated by muscle pump
dysfunction.6 Several studies have measured the prevalence
of varicose veins and reﬂux in the general population,3,7,8
but these studies do not provide longitudinal information
on the risk of developing reﬂux or on how reﬂux is relatedresponding author.
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//dx.doi.org/10.1016/j.ejvs.2014.05.017to future risk of clinical disease. Identifying patients with
reﬂux, or at risk of reﬂux, may be important in the future so
that clinically proven interventions can be administered at
an early stage to halt the progression to clinical disease. The
Edinburgh Vein Study is the ﬁrst longitudinal study to report
on the epidemiology of venous reﬂux in an adult
population.
Duplex ultrasound scanning is considered the gold
standard for the assessment of venous reﬂux because
anatomical and functional haemodynamics can identify
incompetent vein segments.9 Reﬂux is diagnosed where a
clear reverse ﬂow of blood occurs after a period of for-
ward ﬂow in the vein segment. Duplex scanning has been
used in only a few epidemiological studies of varicose
veins.3,8
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were to measure the population incidence of venous
reﬂux and related risk factors, together with the associa-
tions between venous reﬂux at baseline and incidence of
varicose veins and chronic venous insufﬁciency (CVI) at
follow-up.
MATERIALS AND METHODS
Study design
The Edinburgh Vein Study is a prospective population-based
cohort study in which a random age-stratiﬁed sex-speciﬁc
sample of 1566 patients aged 18e64 years were selected at
baseline from general practices in Edinburgh and examined
between 1994 and 1996.2 Follow-up was conducted 13
years later. This study was approved by Lothian Research
Ethics Committee, and each participant gave informed
written consent.Baseline examination
A standardized questionnaire was administered that
covered patient demographics, family history and treat-
ment of venous disease, medical history, smoking, mobility
at work, bowel habit, and obstetric history. Height and
weight were measured for the calculation of body mass
index (BMI). Reﬂux was assessed in ﬁve deep and three
superﬁcial venous segments in each leg using duplex ul-
trasound and classiﬁed as reverse blood ﬂow 0.5 s
following pneumatic cuff compression.7 Clinical venous
disease was assessed using the Basle classiﬁcation.10 Pho-
tographs were taken to document the extent of venous
disease.Follow-up examination
After 13 years, baseline participants were recruited for
follow-up. Updated contact details were obtained through
the Lothian Community Health Index and general practices
identiﬁed where participants were registered. Following an
invitation letter, participants that agreed to take part
attended for follow-up examination. Details of the recruit-
ment process have been described previously.11
Follow-up examinations were conducted by one of four
observers at the Wellcome Trust Clinical Research Facility in
Edinburgh. Venous disease was classiﬁed using the CEAP
system, which comprises of C2 varicose veins; C3 oedema
or corona phlebectatica; C4a pigmentation or eczema; C4b
lipodermatosclerosis or atrophie blanche; C5 healed ulcer-
ation; and C6 active ulceration.12 Within the C2 class, grade
severity was assigned using the Basle system to permit
comparisons with baseline. Oedema was only classiﬁed as
C3 disease if other signs of C2eC6 disease were present.
CVI comprised classes C3eC6.
Reﬂux was assessed with a pulsed Doppler colour ﬂow
imaging HDI 5000 Sono CT duplex scanner (Phillips/ATL,
Bothwell, WA, USA) using a 5.0-MHz linear array probe.
Cephalad venous ﬂow was induced using a cuff around the
calf (width 10 cm, length 50 cm), which was rapidlyinﬂated and deﬂated using an automatic inﬂator (P.M.S
Instruments Ltd, Maidenhead, UK) set to a pressure of
110 mmHg. A minimum of 5 s between compressions
ensured that the veins reﬁlled. For calf segments, a foot
squeeze elicited venous ﬂow. Participants were examined
on a tilting couch at 45 in reversed 15 Trendelenburg
position with their back to the couch and scanned leg
relaxed with the knee slightly bent and weight supported
by the opposite leg. For veins behind the knee, partici-
pants faced the scanner.
Competency was examined in 10 deep and superﬁcial
segments in both legs: (1) common femoral vein (CFV)
proximal to saphenofemoral junction; (2) femoral vein (FV)
2 cm distal to saphenofemoral junction; (3) FV in lower third
of thigh; (4) popliteal vein (POP) above the knee; (5) POP
below the knee; (6) great saphenous vein (GSV) just distal to
the femoral junction; (7) GSV in the lower third of the thigh;
(8) GSV in the upper calf; (9) GSV in the lower calf; and (10)
small saphenous vein (SSV) just distal to the saphenopo-
pliteal junction. Reﬂux was not measured in the tributaries.
Two measures of reﬂux to nearest hundredth second were
made in each segment using callipers on the spectral
Doppler trace, with the average determining reﬂux dura-
tion. Venous reﬂux was deﬁned as reversed blood ﬂow
0.5 s.Inter- and intraobserver reliability
Periodically during follow-up, repeat measures were per-
formed on 49 participants to assess observer variability of
duplex scanning. For interobserver reliability, the same leg
was scanned independently by two observers; for intra-
observer reliability, one leg was re-scanned by the same
observer after at least 12 weeks. The results showed good
reliability: interobserver agreement ranged from 84% to
99% for deep reﬂux and from 80% to 96% for superﬁcial
reﬂux; intraobserver agreement ranged from 79% to 100%
and from 78% to 90% for deep and superﬁcial veins
respectively.Statistical analysis
Data collected at the baseline and follow up examinations
were checked, coded, and double entered by two re-
searchers into the university’s computer system. SPSS-X
software (IBM, Armonk, NY, USA) was used for statistical
analysis. A chi-square test was used for nominal categori-
cal data and to test for linear trend for ordered categorical
data. A p-value  0.05 denoted statistical signiﬁcance.
Age- and sex-adjusted odds ratios (ORs) with 95% conﬁ-
dence intervals (CIs) were calculated for the incidence of
venous reﬂux. The incidence of venous reﬂux was deﬁned
as the number of patients with no venous reﬂux at base-
line who developed venous reﬂux in any of the vein seg-
ments in any leg at follow-up. Incidence of C2eC6 disease
was deﬁned as the number of patients with no C2eC6
disease at baseline who developed C2eC6 disease in any
leg at follow-up.
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Study sample
Of 1566 baseline participants, 101 died and nine emigrated
during the follow-up period; thus, invitations were sent to
1456 of whom 880 participated (response rate 60.4%). Mean
(SD) duration of follow-up was 13.4 (0.4) years. At follow up,
99.5% were white, 55.7% were women, and the mean (SD)
age was 60.0 (11.5) years, which did not differ by gender
(p ¼ .32). Participants were older than nonparticipants
(mean [SD] age 60.0 [11.5] years vs. 55.2 [13.5] years,
p < .01). They had a higher baseline prevalence of C1 tel-
angiectases (92.1% vs. 86.2%, p¼ .01) and C1 reticular veins
(90.2% vs. 86.6%, p¼ 0.02), and had more previous varicose
vein surgery (7.9% vs. 4.5%, p¼ .02) and sclerotherapy (4.6%
vs. 2.6%, p ¼ .04) at baseline. However, participants and
nonparticipants did not differ in baseline prevalence of C2
varicose veins (36.8% vs. 34.8%, p ¼ .40) and C3eC6 CVI
(5.6% vs. 5.7%, p ¼ .80). Compared with the population of
Edinburgh,13 the study sample contained a slightly higher
proportion of women (55.7% vs. 51.6%, p ¼ .02), but had
similar levels of deprivation (mean Scottish Index of Multiple
Deprivation quintile 3.9 vs. 3.7, p ¼ .18).13
Incidence of reﬂux
Of 306 participants free from reﬂux at baseline, 39 had new
reﬂux at follow-up: the 13-year incidence was 12.7% (95% CI
9.2e17.2) and the annual incidence 0.9% (95% CI 0.7e1.3).
Incidence did not differ signiﬁcantly between right and left
legs (p > .05) and was higher in the superﬁcial than deep
system (Table 1). Only one of 306 patients had surgery or
sclerotherapy during the 13-year follow-up period. Further
analysis (data not shown) did not show any differences be-
tween men and women, or by age group, but the results
were imprecise owing to small numbers of new reﬂux in
these subgroups. Reﬂux developed most commonly in the
GSV, particularly the lower third of the thigh where the
incidence was 8.1% (95% CI 5.4e11.8). Incidence in the deep
system was low: POP below knee was the most affected with
an incidence of 2.9% (95% CI 1.4e5.3).
Risk factors and incidence of reﬂux
Table 2 presents the incidence of reﬂux at follow-up ac-
cording to risk factors at baseline. The age and sex-adjustedTable 1. Thirteen-year incidence of venous reﬂux of 0.5 s duration.
Type of reﬂux at follow up Right leg
n/Na % (95% CI)b
Deep reﬂux onlyc 7/306 2.3 (1.0e4.5)
Superﬁcial reﬂux onlyd 15/306 4.9 (2.5e7.3)
Combined reﬂuxe 1/306 0.3 (0.1e1.6)
Note. CFV ¼ common femoral vein; FV ¼ femoral vein; POP ¼ poplite
a n ¼ number of participants with venous reﬂux 0.5 s duration at follo
valid reﬂux measurements at follow-up.
b Thirteen-year incidence of venous reﬂux.
c Deep reﬂux only ¼ reﬂux in CFV, FV, or POP and no reﬂux in GSV or
d Superﬁcial reﬂux only ¼ reﬂux in GSV or SSV and no reﬂux in CFV, F
e Combined reﬂux ¼ reﬂux CFV, FV, or POP, and reﬂux GSV or SSV inOR was 2.1 (95% CI 1.0e4.4) in overweight compared with
normal-weight participants. History of deep vein thrombosis
(DVT) also appeared to be a risk factor for reﬂux (OR 11.3,
95% CI 1.0e132.3), but was based on only three patients
with DVT. Family history of venous disease, superﬁcial
thrombophlebitis, pregnancy, use of oral contraceptives and
hormone replacement therapy, smoking, mobility at work,
or bowel movement were not signiﬁcant risk factors.Reﬂux and incidence of venous disease
In determining the incidence of clinical disease in relation to
reﬂux, 15 of 554 patients had surgery or sclerotherapy.
Fig. 1 shows that in participants with no C2eC6 disease at
baseline the incidence of C2 varicose veins was 12.9% (95%
CI 8.8e17.0) if no reﬂux at baseline compared with 25.8%
(95% CI 19.7e31.9) in those with reﬂux. In the 256 partic-
ipants with no reﬂux at baseline, the incidence of varices
was 9.2% (95% CI 7.4e11.0) if no reﬂux at follow-up, but
was 26.2% (95% CI 22.6e29.8) if there was reﬂux at follow-
up (data not shown). The 13-year incidence of C3eC6 CVI
was 11.1% (95% CI6.7e15.5) and 9.8% (95% CI 6.2e13.4) in
those with and without reﬂux at baseline respectively
(p ¼ .04). If there was no reﬂux at baseline, the incidence of
CVI was 2.7% (95% CI 1.9e3.5) if no reﬂux at follow-up
compared with 10.4% (95% CI 8.0e12.8) if there was
reﬂux at follow-up (data not shown). Thus, for patients with
reﬂux at baseline or who developed reﬂux during follow-up,
the incidence of both varicose veins and CVI was higher
than in those who never had reﬂux.
When analysed by system, reﬂux conﬁned to the deep
veins was not associated with the development of varicose
veins (OR 1.1, 95% CI 0.5e2.4) in contrast to superﬁcial
reﬂux (OR 4.4, 95% CI 1.8e10.8). If combined deep and
superﬁcial reﬂux was present, the OR for varicose veins was
even higher (7.3, 95% CI 2.6e22.5). Deep (p ¼ .61), su-
perﬁcial (p ¼ .11) or combined reﬂux (p ¼ .40) at baseline
were not associated with increased incidence of CVI.
Table 3 presents the incidence of C2eC6 disease ac-
cording to reﬂux in individual vein segments in the right leg.
In the deep veins, reﬂux in the lower thigh FV and above
and below knee POP were associated with development of
varices at follow up with ORs between 2.7 and 3.7. Reﬂux in
the GSV was even more strongly associated with an
increased incidence. For C3eC6 CVI, no vein segment wasLeft leg Any leg
n/Na % (95% CI)b n/Na % (95% CI)b
2/305 0.7 (0.1e2.2) 8/305 2.6 (1.2e5.0)
15/305 4.9 (2.5e7.3) 27/305 8.8 (5.6e12.0)
3/305 1.0 (0.3e2.7) 4/305 1.3 (0.4e3.2)
al vein; GSV ¼ great saphenous vein; SSV ¼ small saphenous vein.
w up; N ¼ number of participants free from reﬂux at baseline with
SSV in any leg at follow-up.
V, or POP in any leg at follow-up.
any leg at follow-up.
Table 2. Thirteen-year incidence of venous reﬂux of 0.5 s
duration at follow-up by risk factors at baseline.
Risk factor at baseline 13-Year incidence of venous reﬂux
n/Na Adjusted OR (95% CI)b
BMIc
Normal 14/149 1.0
Overweight 20/114 2.1 (1.0e4.4)
Obese 5/43 1.2 (0.4e3.5)
Family history of venous diseased
No 21/184 1.0
Yes 17/114 1.4 (0.7e2.7)
History of DVT
No 37/301 1.0
Yes 2/3 11.3 (1.0e132.3)
Superﬁcial thrombophlebitis
No 37/299 1.0
Yes 2/6 2.8 (0.5e16.5)
Pregnancy
Never pregnant 8/46 1.0
Ever pregnant 17/129 0.6 (0.2e1.6)
Oral contraceptive use
No 8/41 1.0
Yes 15/130 0.5 (0.2e1.4)
HRT
No 18/142 1.0
Yes 7/30 2.1 (0.7e5.9)
Smoking
Never smoked 22/162 1.0
Current smoker 6/63 0.7 (0.2e1.7)
Ex-smoker 11/81 0.9 (0.4e2.0)
Mobility at worke
Sitting 14/124 1.0
Standing 4/34 1.0 (0.3e3.2)
Walking 9/53 1.5 (0.6e3.8)
Heavy lifting 8/49 1.5 (0.6e3.9)
Strain to start a bowel movement
No 34/265 1.0
Yes 5/41 0.9 (0.3e2.5)
Strain to ﬁnish a bowel movement
No 34/274 1.0
Yes 5/31 1.1 (0.4e3.4)
Note. OR ¼ odds ratio; CI ¼ conﬁdence interval; BMI ¼ body mass
index; DVT ¼ deep vein thrombosis; HRT ¼ hormone replacement
therapy.
a n ¼ number of participants with risk factor at baseline and new
reﬂux at follow up, N ¼ total number of participants with risk
factor at baseline.
b Age and sex-adjusted odd ratio (95% conﬁdence interval).
c Normal weight ¼ BMI 18.5e24.99 kg/m2, overweight ¼ BMI
25.0e29.99 kg/m2, obese ¼ BMI  30 kg/m2.
d Maternal or paternal history of C2eC6 CEAP chronic venous
disease.
e Mobility at work according to >50% of time spent sitting,
standing, walking, or heavy lifting at work.
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ticipants with reﬂux at baseline who developed CVI at
follow up were small. Results were similar for the left leg
(data not shown).
Disease incidence rates were related to the numbers of
segments with reﬂux (Fig. 2). The 13-year incidence of
varices was 9.5% (95% CI 6.9e12.7) if there was no reﬂux inthe deep or superﬁcial segments, and increased linearly to
35.3% (95% CI 14.3e73.4) if three or more segments were
affected (p < .01). For superﬁcial veins, the incidence was
8.8% (95% CI 6.3e12.0) if there was no reﬂux, rising to
42.9% (95% CI 10.9e116.6) if two segments were affected
(p < 0.0 1).DISCUSSION
Incidence of reﬂux
The incidence of venous reﬂux at 13 years in the Edinburgh
Vein Study was 12.7% (95% CI 9.2e17.2) equating to an
annual incidence rate of 0.9% (95% CI 0.7e1.3). Incidence
was highest in the superﬁcial system, particularly in the GSV
lower third of the thigh, and was much lower in the deep
system. Incidence did not differ by age and sex or between
left and right legs. Incidence in adults has not been re-
ported previously, but the Bochum Study investigated chil-
dren and found that GSV and SSV reﬂux did occur, and with
an increasing incidence with age.14 The Bonn Vein Study has
not reported on incidence, but has shown some differences
in prevalence, namely a higher prevalence of superﬁcial
reﬂux in women and a higher prevalence of deep venous
reﬂux in men,15 as reported in the Edinburgh Vein Study at
baseline.14Risk factors
Obesity, family history, DVT, pregnancy, smoking and
mobility at work have been proposed as risk factors, but
none have shown consistently positive associations in
prevalence studies of venous reﬂux,1,4,5,16 nor have they
been investigated in longitudinal studies. We found that
being overweight (BMI 25.0e29.9 kg/m2) was a risk factor
for reﬂux, but not obesity (BMI  30 kg/m2). However, the
lack of a statistical association for obesity may have been
due to small numbers. The Bonn Vein Study found no as-
sociation between BMI and the prevalence of venous reﬂux
in the deep or superﬁcial system.15 It has been hypoth-
esised that overweight patients have increased abdominal
pressures impeding venous ﬂow from the legs leading to
reﬂux.17 The results presented herein also suggest that a
history of DVT might be associated with development of
reﬂux. DVT is an established contributing factor to the
development of venous reﬂux because thrombus can
obstruct venous ﬂow causing dilation with secondary valve
incompetence.18
The other factors implicated in the aetiology of venous
disease in this study were not associated with reﬂux. This
included pregnancy, in which theories of an effect on reﬂux
are conﬂicting. It has been suggested that the pressure of
the uterus on the iliac veins causes valves to become
incompetent.19 However, this is considered unlikely owing
to varices often appearing during early pregnancy when the
uterus is small.20 Another theory is that an increase in
circulating hormones affects venous dilation and causes
valve failure.21 Smoking was also not a signiﬁcant risk factor,
which is in keeping with the lack of association found in
Figure 1. Incidence of clinical venous disease according to reﬂux status at baseline and follow-up. Note. CVI ¼ chronic venous insufﬁciency.
a Valid reﬂux measurements only available in 454 (82%) of participants. Data missing owing to no blood ﬂow through vein or missing vein
segment. b C3eC6 includes some participants with C2 varicose veins. Oedema only classiﬁed as C3 if other signs of C2eC6 disease were
present.
212 L.A. Robertson et al.most cross-sectional studies of varicose veins.22e26 We also
found that mobility at work was not related to the risk of
reﬂux. Standing for prolonged periods of time results in
increased hydrostatic pressure, which impedes blood ﬂow
and impairs the calf muscle pump, leading to venous stasis
in the legs.27 However, results on the effect of standing on
prevalence of varicose veins are conﬂicting,22,26,28e33 but
may be related to difﬁculties in obtaining valid measure-
ments. Furthermore, there is no evidence that Africans
stand for less time than Europeans, yet the prevalence of
venous disease in the former seems to be lower.34Table 3. Thirteen-year incidence of varicose veins and chronic venou
duration in right leg at baseline.
Reﬂux at baseline C2 varicose veins
% (95% CI)a n/Nb Adjust
Deep vein segment
CFV 16.0 (5.1e38.6) 4/25 1.6 (0
FV 20.0 (8.1e41.6) 6/30 2.1 (0
FV lower thigh 28.0 (12.2e55.4) 7/25 3.7 (1
POP above knee 26.1 (14.1e44.3) 12/46 3.2 (1
POP below knee 23.1 (12.5e39.2) 12/52 2.7 (1
Superﬁcial vein segment
GSV origin 42.9 (10.9e116.6) 3/7 5.8 (1
GSV lower thigh 40.0 (21.7e68.0) 12/30 7.1 (3
SSV 30.0 (7.6e81.6) 3/10 3.2 (0
Note. CI ¼ conﬁdence interval; OR ¼ odds ratio; CFV ¼ common fem
saphenous vein; SSV ¼ small saphenous vein.
a Thirteen-year incidence (95% CI) of C2 varicose veins or C3eC6 CVI.
b n ¼ number of participants with reﬂux of 0.5 s at baseline and C2
reﬂux of 0.5 s at baseline.
c OR for varicose veins or CVI in those with reﬂux in speciﬁc vein segReﬂux and incidence of venous disease
In this study, the incidence of varicose veins was strongly
linked to the type of venous reﬂux at baseline. The risk of
developing varicose veins was lowest if no reﬂux, followed
by deep reﬂux, then superﬁcial reﬂux, and was highest with
combined deep and superﬁcial reﬂux. Labropoulos et al.
studied 90 patients for reﬂux and progression of disease
and reported that, in those with venous reﬂux conﬁrmed by
duplex ultrasound, one-third had progressed to a more
severe CEAP class within 6 months.35 The Bochum Study
found that a preclinical reﬂuxing superﬁcial vein in childrens insufﬁciency (CVI) in right leg by presence of reﬂux of 0.5 s
C3eC6 CVI
ed ORc % (95% CI)a n/Nb Adjusted ORc
.5e4.8) 0 0/23 0
.8e5.4) 14.3 (4.5e35.4) 4/28 2.6 (0.8e8.5)
.4e9.7) 8.7 (1.4e28.7) 2/23 1.3 (0.3e6.3)
.6e6.7) 6.8 (1.7e18.5) 3/44 1.2 (0.3e4.0)
.3e5.5) 8.0 (2.5e19.3) 4/50 1.5 (0.5e4.4)
.2e27.3) 14.3 (0.7e70.4) 1/7 1.5 (0.2e13.5)
.1e16.3) 10.0 (2.5e27.2) 3/30 1.4 (0.4e4.9)
.8e13.0) 11.1 (0.6e54.8) 1/9 0.9 (0.1e7.6)
oral vein; FV ¼ femoral vein; POP ¼ popliteal vein; GSV ¼ great
or C3eC6 disease at follow up, N ¼ number of participants with
ment vs. no reﬂux (adjusted for age and sex).
Figure 2. Thirteen-year incidence of varicose veins at follow-up
according to number of vein segments with reﬂux 0.5 s dura-
tion at baseline.
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4 years.36 Similarly, we found that those with a preclinical
reﬂuxing superﬁcial vein were 4.4 (95% CI 1.8e10.8) times
more likely to develop varicose veins after 13 years. Reﬂux
in the GSV, particularly in the origin and lower third of
thigh, were the key segments. Labroupoulos et al. also
identiﬁed above the knee GSV reﬂux as an important risk
factor for varicose veins.37 However, deep reﬂux is known
to be an important cause of ulceration.38e40Study limitations
Periodically, observers at both baseline and follow-up un-
derwent quality control testing and the results demon-
strated good inter- and intraobserver reliability at both time
points. However, determination of the extent of measure-
ment variability between baseline and follow-up was not
possible, which might have affected the accuracy of the
incidence estimates and masked some associations.
Another limitation was the small number of participants
who developed CVI or had risk factors such as DVT; results
from these small subgroups must be interpreted with
caution and, in particular, it cannot be assumed that venous
reﬂux is not related to the development of CVI.
In this study, abnormal venous reﬂux was deﬁned as
0.5 s. However, debate exists on how many seconds of
retrograde ﬂow constitute ‘signiﬁcant’ reﬂux, with sensi-
tivity and speciﬁcity varying according to cut-point, partic-
ularly for the femoropopliteal veins.41 Furthermore, our
results are only valid for the predeﬁned segments of the
venous system in which standardised duplex was per-
formed. Finally, the gastrocnemius, calf and perforating
veins were not scanned, and it is possible that these are
related to popliteal reﬂux and are important in develop-
ment of venous disease.
CONCLUSIONS
The Edinburgh Vein Study is the ﬁrst longitudinal study to
report on the incidence of venous reﬂux and associated riskfactors in an adult population. Key vein segments have been
identiﬁed as important contributing factors in the devel-
opment of C2 varicose veins.
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